Sanofi Pays $25 Million to Settle SEC Bribery Charges

Posted 10/4/18

French pharmaceutical company Sanofi agreed Sept. 4, 2018, to pay more than $25 million to resolve Securities and Exchange Commission (SEC) charges that it violated the Foreign Corrupt Practices Act …

This item is available in full to subscribers.

Please log in to continue

Log in